gdc

Web Exclusives

Oncology Social Workers: The Unsung Heroes of the Cancer Journey
Doctors and nurses are heroes for the care they provide, and researchers are heroes for the breakthrough treatments and medications they develop. Let us not overlook the incredible contributions of oncology social workers in the journey of a patient with cancer.
A Healthy Diet May Reduce the Risk of Cancer
Nutrition & Cancer
Based on current and evolving scientific evidence, the cancer prevention guidelines have been shifting from a nutrient-centric approach to a more holistic approach of diet that is characterized as dietary patterns.
Can You Get Pregnant If You Have Cervical Cancer?
Cervical Cancer
Cervical cancer during pregnancy can be successfully managed with a multidisciplinary treatment team and an individualized treatment strategy that optimizes maternal treatment while considering fetal safety.
FDA Approved Fyarro for Malignant Perivascular Epithelioid-Cell Tumor
FDA Approvals, News & Updates

On November 22, 2021, the FDA approved Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound); from Aadi Bioscience) for adults with locally advanced, unresectable or metastatic malignant perivascular epithelioid-cell tumor (PEComa), a rare type of mesenchymal tumors that can occur in any part of the body.

Jemperli a New Immunotherapy Approved for All Patients with dMMR Solid Tumors
FDA Approvals, News & UpdatesImmunotherapy
On August 17, 2021, the FDA accelerated the approval of Jemperli (dostarlimab-gxly; from GlaxoSmithKline) injection, an immunotherapy and a PD-1 inhibitor, for the treatment of all adults with recurrent (coming back) or advanced mismatch repair-deficient (dMMR) solid tumors, including lung cancer, that progressed during or after systemic therapy and for whom there are no satisfactory alternative treatment options.
Reasons for Optimism for Patients with Cancer Facing Another Winter with COVID-19
COVID-19 & Cancer
Although we are entering another winter with the ongoing prevalence of the coronavirus, we have come a long way since the initial outbreak. Here are some reasons for patients to be optimistic for the season.
Combining Targeted Therapies in CLL
CLL Monthly MinutesLeukemia
The combination of acalabrutinib, venetoclax, and obinutuzumab has been shown to be an active regimen in previously untreated patients with CLL.
A Comprehensive Analysis of COVID-19 in Patients with CLL
CLL Monthly MinutesLeukemia
During the first 13 months of the pandemic, COVID-19 continued to result in high hospitalization rates among patients with CLL.
Infections in Patients with CLL Receiving Ibrutinib
CLL Monthly MinutesLeukemia
Identifying the risk factors for infection may allow preventive measures to be taken to protect patients.
Page 2 of 23
Results 11 - 20 of 227

Subscribe to CONQUER: the patient voice

Receive timely cancer news & updates, patient stories, and more.


Country
Race or Ethnicity
Gender
Profession or Role
Primary Interest
Other Interests